ClinicalTrials.gg
Not yet recruitingNCT06615297Updated Sep 26, 2024

Mimic Muscle Volume, Central Facial Palsy Severity and Dysphagia

An observational study in Facial Paralysis, Central and Stroke, sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-26.

Sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 8 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

70 stroke patients with central facial paralysis will be included and their demographic data will be questioned and facial nerve thickness, depressor labi inferior, depressor anguli oris, buccinator and risorius muscles will be evaluated.

Read the detailed description

70 stroke patients with central facial paralysis who were included in the rehabilitation program at Istanbul Physical Therapy and Rehabilitation Training and Research Hospital will be included and their demographic data such as age, gender, marital status, education level, body mass index, stroke etiologies will be questioned and used with the House-Brackmann scale. Involvement levels, facial nerve thickness (right/left), depressor labi inferior, depressor anguli oris, buccinator and risorius muscles will be evaluated. The data obtained will be correlated with total dysphagia score and facial disability index.

02

Conditions studied

  • Facial Paralysis, Central
  • Stroke
03

In context

Facial Paralysis

81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.

This study's planned enrollment of 70 is below the median of 80 across 21 observational studies indexed under Facial Paralysis.

Browse Facial Paralysis studies →

Lead sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital is the lead sponsor of 123 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

70 stroke patients with central facial paralysis who were included in the rehabilitation program at Istanbul Physical Therapy and Rehabilitation Training and Research Hospital will be included

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of stroke and presence of unilateral central facial paralysis,
  • Agreeing to participate in the study,
  • Cognitive competence to understand the test instructions,
  • Presence of communication skills to respond to the test instructions.

Exclusion criteria

Exclusion Criteria:

  • Presence of previous facial paralysis or a neurological disease other than stroke that will cause central paralysis,
  • bilateral involvement
  • illiteracy, refusal to participate in the study,
  • jaw joint problem,
  • surgical intervention in the facial area that will affect ultrasound measurements,
  • infected open wound.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • central facial paralysis

    70 stroke patients with central facial paralysis who were included in the rehabilitation program at Istanbul Physical Therapy and Rehabilitation Training and Research Hospital will be included

    Diagnostic Test: ultrasonographic evaluation

Interventions

  • Diagnostic testultrasonographic evaluation

    facial nerve thickness (right/left), depressor labi inferior, depressor anguli oris, buccinator and risorius muscles will be evaluated.

06

What researchers measure

Primary outcomes

  1. facial nerve thickness

    the thickness of the nerve will be measured by ultrasound

    Time frame: baseline

Secondary outcomes

  1. depressor labi inferior

    the thickness of the muscle will be measured by ultrasound

    Time frame: baseline

  2. depressor anguli oris

    the thickness of the muscle will be measured by ultrasound

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2024; primary completion for Mar 2025, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2024
First posted
Sep 26, 2024
StartEst.
Oct 1, 2024
Primary completionEst.
Mar 1, 2025
CompletionEst.
Apr 1, 2025
Last update
Sep 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06615297
Responsible party
Sponsor
First posted
Sep 26, 2024
Start date
Oct 1, 2024 (estimated)
Primary completion
Mar 1, 2025 (estimated)
Completion
Apr 1, 2025 (estimated)
Last update
Sep 26, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion